Different Functional and Structural Characteristics between ApoA-I and ApoA-4 in Lipid-Free and Reconstituted HDL State: ApoA-4 Showed Less Anti-Atherogenic Activity |
Yoo, Jeong-Ah
(School of Biotechnology, Yeungnam University)
Lee, Eun-Young (School of Biotechnology, Yeungnam University) Park, Ji Yoon (Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University) Lee, Seung-Taek (Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University) Ham, Sihyun (Department of Chemistry, Sookmyung Women's University) Cho, Kyung-Hyun (School of Biotechnology, Yeungnam University) |
1 | Li, X., Xu, M., Wang, F., Kohan, A.B., Haas, M.K., Yang, Q., Lou, D., Obici, S., Davidson, W.S., and Tso, P. (2014). Apolipoprotein A-IV Reduces Hepatic Gluconeogenesis through the Nuclear Receptor NR1D1. J. Biol. Chem. 289, 2396-2404. DOI ScienceOn |
2 | Mahley, R.W., Innerarity, T.L., Rall, S.C., and Weisgraber, K.H. (1984). Plasma lipoproteins: apolipoprotein structure and function. J. Lipid Res. 25, 1277-1294. |
3 | Main, L.A., Ohnishi, T., and Yokoyama, S. (1996). Activation of human plasma cholesteryl ester transfer protein by human apolipoprotein A-IV. Biochim. Biophys. Acta 1300, 17-24. DOI ScienceOn |
4 | Markwell, M.A., Haas, S.M., Bieber, L.L., and Tolbert, N.E. (1978). A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87, 206-210. DOI ScienceOn |
5 | Matz, C.E., and Jonas, A. (1982). Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J. Biol. Chem. 257, 4535-4540. |
6 | McPherson, J.D., Shilton, B.H., and Walton, D.J. (1988). Role of fructose in glycation and cross-linking of proteins. Biochemistry 27, 1901-1907. DOI ScienceOn |
7 | Park, K.H., Jang, W., Kim, K.Y., Kim, J.R., and Cho, K.H. (2010). Fructated apolipoprotein A-I showed severe structural modifycation and loss of beneficial functions in lipid-free and lipid-bound state with acceleration of atherosclerosis and senescence. Biochem. Biophys. Res. Commun. 392, 295-300. DOI ScienceOn |
8 | Park, J.Y., Park, J.H., Jang, W., Hwang, I.K., Kim, I.J., Kim, H.J., Cho, K.H., and Lee, S.T. (2012). Apolipoprotein A-IV is a novel substrate for matrix metalloproteinases. J. Biochem. 151, 291-298. DOI ScienceOn |
9 | Park, K.H., Kim, J.M., and Cho, K.H. (2014). Elaidic acid (EA) generates dysfunctional high-density lipoproteins and consumption of EA exacerbates hyperlipidemia and fatty liver change in zebrafish. Mol. Nutr. Food Res. 58, 1537-1545. DOI ScienceOn |
10 | Pownall, H.J., Massey, J.B., Kusserow, S.K., and Gotto, A.M. (1978). Kinetics of lipid-protein interactions: interaction of apolipoprotein A-I from human plasma high density lipoproteins with phosphatidylcholines. Biochemistry 17, 1183-1188. DOI ScienceOn |
11 | Pearson, K., Saito, H., Woods, S.C., Lund-Katz, S., Tso, P., Phillips, M.C., and Davidson, W.S. (2004). Structure of human apolipoprotein A-IV: a distinct domain architecture among exchangeable apolipoproteins with potential functional implications. Biochemisty 43, 10719-10729. DOI ScienceOn |
12 | Qin, X., Swertfeger, D.K., Zheng, S., Hui, D.Y., and Tso, P. (1998). Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation. Am. J. Physiol. 274, H1836-H1840 |
13 | Staros, J.V. (1982). N-hydroxysulfosuccinimide active esters: bis(Nhydroxysulfosuccinimide) esters of two dicarboxylic acids are hydrophilic, membrane-impermeant, protein cross-linkers. Biochemistry 21, 3950-3955. DOI ScienceOn |
14 | Steinmetz, A., and Utermann, G. (1985). Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-I. J. Biol. Chem. 260, 2258-2264. |
15 | Tubb, M.R., Silva, R.A., Fang, J., Tso, P., and Davidson, W.S. (2008). A three-dimensional homology model of lipid-free apolipoprotein A-IV using cross-linking and mass spectrometry. J. Biol. Chem. 283, 17314-17323. DOI ScienceOn |
16 | Tubb, M.R., Smith, L.E., and Davidson, W.S. (2009). Purification of recombinant apolipoproteins A-I and A-IV and efficient affinity tag cleavage by tobacco etch virus protease. J. Lipid Res. 50, 1497-1504. DOI ScienceOn |
17 | Boguski, M.S., Elshourbagy, N., Taylor, J.M., and Gordon, J.I. (1984). Rat apolipoprotein A-IV contains 13 tandem repetitions of a 22-amino acid segment with amphipathic helical potential. Proc. Natl. Acad. Sci. USA 81, 5021-5025. DOI |
18 | VerHague, M.A., Cheng, D., Weinberg, R.B., and Shelness, G.S. (2013). Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion. Arterioscler. Thromb. Vasc. Biol. 33, 2501-2508. DOI ScienceOn |
19 | Weinberg, R.B. (2002). Apolipoprotein A-IV polymorphisms and diet-gene interactions. Curr. Opin. Lipidol. 13, 125-134. DOI ScienceOn |
20 | Beisiegel, U., and Utermann, G. (1979). An apolipoprotein homolog of rat apolipoprotein A-IV in human plasma. Isolation and partial characterization. Eur. J. Biochem. 93, 601-608 DOI ScienceOn |
21 | Brouillette, C.G., Anantharamaiah, G.M., Engler, J.A., and Borhani, D.W. (2001). Structural models of human apolipoprotein A-I: a critical analysis and review. Biochim. Biophys. Acta. 1531, 40-46. |
22 | Cho, K.H. (2011). Enhanced delivery of rapamycin by V156K-apoAI high-density lipoprotein inhibits cellular proatherogenic effects and senescence and promotes tissue regeneration. J. Gerontol. A. Biol. Sci. Med. Sci. 66, 1274-1285. |
23 | Chen, P.S., Toribara, T.Y., and Warner, H. (1956). Microdetermination of phosphorus. Anal .Chem. 28, 1756-1758. DOI |
24 | Chen, Y.H., Yang, J.T., and Martinez, H.M. (1972). Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion. Biochemistry 11, 4120-4131. DOI ScienceOn |
25 | Cho, K.H. (2009). Biomedicinal implications of high-density lipoprotein: its composition, structure, functions, and clinical applications. BMB Rep. 42, 393-400. DOI ScienceOn |
26 | Cho, K.H., Park, S.H., Han, J.M., Kim, H.C., Choi, Y.K., and Choi, I. (2006). ApoA-I mutants V156K and R173C promote antiinflammatory function and antioxidant activities. Eur. J. Clin. Invest. 36, 875-882. DOI ScienceOn |
27 | Davidson, W.S., Hazlett, T., Mantulin, W.W., and Jonas, A. (1996). The role of apolipoprotein A-I domains in lipid binding. Proc. Natl. Acad. Sci. USA 93, 13605-13610. DOI ScienceOn |
28 | Ezeh, B., Haiman, M., Alber, H.F., Kunz, B., Paulweber, B., Lingenhel, A., Kraft, H.G., Weidinger, F., Pachinger, O., Dieplinger, H., et al. (2003). Plasma distribution of apoA-IV in patients with coronary artery disease and healthy controls. J. Lipid Res. 44, 1523-1529. DOI ScienceOn |
29 | Ferretti, G., Bacchetti, T., Bicchiega, V., and Curatola, G. (2002). Effect of human Apo AIV against lipid peroxidation of very low density lipoproteins. Chem. Phys. Lipids 114, 45-54. DOI ScienceOn |
30 | Fraenkal-Conrat, H. (1957). Methods for investigating essential groups for enzyme activity, Meth. Enzymol. 4, 247-269. DOI |
31 | Frank, P.G., and Marcel, Y.L. (2000). Apolipoprotein A-I: structurefunction relationships. J. Lipid Res. 41, 853-872. |
32 | Goldberg, I.J., Scheraldi, C.A., Yacoub, L.K., Saxena, U., and Bisgaier, C.L. (1990). Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. J. Biol. Chem. 265, 4266-4272. |
33 | Gomaraschi, M., Putt, W.E., Pozzi, S., Iametti, S., Barbiroli, A., Bonomi, F., Favari, E., Bernini, F., Franceschini, G., Talmud, P.J., et al. (2010). Structure and function of the apoA-IV T347S and Q360H common variants. Biochem. Biophys. Res. Commun. 393, 126-130 DOI ScienceOn |
34 | Han, J.M., Jeong, T.S., Lee, W.S., Choi, I., and Cho, K.H. (2005). Structural and functional properties of V156K and A158E mutants of apolipoprotein A-I in the lipid-free and lipid-bound states. J. Lipid Res. 46, 589-596. DOI |
35 | Havel, R.J., Eder, H.A., and Bragdon, J.H. (1955). The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34, 1345-1353. DOI ScienceOn |
36 | Heider, J.G., and Boyett, R.L. (1978). The picomole determination of free and total cholesterol in cells in culture. J. Lipid Res. 19, 514-518. |
37 | Jonas, A. (1998). Regulation of lecithin cholesterol acyltransferase activity. Prog. Lipid Res. 37, 209-234. DOI ScienceOn |
38 | Kim, J.Y., Kim, H., Jung, B.J., Kim, N.R., Park, J.E., and Chung, D.K. (2013). Lipoteichoic acid isolated from Lactobacillus plantarum suppresses LPS-mediated atherosclerotic plaque inflammation. Mol. Cells 35, 115-124. DOI |